Unichem Laboratories receives USFDA approval for Amitriptyline HCl Tablets
Capital MarketUnichem Laboratories is pleased to announce that it has received ANDA approval for its Amitriptyline HCl Tablets USP, 10 mg, 25 mg, 50 mg, 75 mg, 100 mg and 150 mg from the United States Food and Drug Administration (USFDA) to market a generic version of ELAVIL (Amitriptyline Hydrochloride) 10 mg, 25 mg, 50 mg, 75 mg, 100 mg and 150 mg of AstraZeneca Pharmaceuticals LP.
Amitriptyline HCl Tablets are indicated for the relief of symptoms of depression. The product will be commercialized from Unichem's Goa Plant.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
